Greenstone Biosciences

To support the important work happening in academic research labs around the world, we continue to offer complimentary human induced pluripotent stem cell (hiPSC) lines (processing and shipping not included) to academic researchers. Details below ⬇️

Come find us at booth number 2310 for the 2026 @SOToxicology (SOT) and @ToxExpo annual meeting, from Sunday, March 22nd to Wednesday, March 25th! Learn more here: toxicology.org/events/am/AM20…

Over the past several weeks we at Greenstone Biosciences have highlighted a number of rare diseases represented in our iPSC biobank. Today we are wrapping up that series and exploring the impact NAMs are having on rare disease research. Read More: linkedin.com/posts/greensto…

The newest @GreenstoneBio Webinar: Human Pluripotent Stem Cells, Organoids, and Drug Discovery featuring Dr. Shuibing Chen, Director of the Center of Genomic Health at Weill Cornell Medicine, is now available to watch online! youtube.com/watch?v=Kkee6t…

Continuing on from Rare Disease Day this last Saturday, we at @GreenstoneBio are continuing to spotlight rare diseases represented in our iPSC biobank. This week, we are highlighting rare cancers. Read more here: linkedin.com/posts/greensto…

We are thrilled to see our Co-Founder @Joseph_C_Wu featured in a news article in @Nature exploring the future of biomedical research and the global shift away from animal testing. Read more here: linkedin.com/posts/greensto…

Just one day away! Tomorrow is the newest entry in the @GreenstoneBio webinar series, featuring Dr. @ChenShuibing, Director of the Center of Genomic Health at @WeillCornell. Join us Tomorrow, February 27th at 10 AM PDT / 1 PM EDT: us06web.zoom.us/webinar/regist…

As we count down to Rare Disease Day on February 28, we at @GreenstoneBio are continuing to spotlight rare diseases represented in our iPSC biobank. This week, we are highlighting metabolic rare diseases. Read more here: linkedin.com/posts/greensto…

This coming Friday is the newest entry in the @GreenstoneBio webinar series, featuring Dr. @ChenShuibing, Director of the Center of Genomic Health at @WeillCornell. Join us on Friday, February 27th at 10 AM PDT / 1 PM EDT: us06web.zoom.us/webinar/regist…

We’re excited to announce that @GreenstoneBio is partnering with Neolaia Bio to advance next-generation therapies for inflammatory bowel disease (IBD) using human-relevant disease models Read the press release here: biospace.com/press-releases…

As we count down to Rare Disease Day on February 28, we at @GreenstoneBio are continuing to spotlight rare diseases represented in our iPSC biobank. This week, we are highlighting cardiovascular rare diseases. Read more here: linkedin.com/posts/greensto…

We are excited to announce the newest entry in the Greenstone Biosciences webinar series, featuring Dr. @ChenShuibing, Director of the Center of Genomic Health at @WeillCornell. Join us on Friday, February 27th at 10 AM PDT / 1 PM EDT: us06web.zoom.us/webinar/regist…

@GreenstoneBio is offering patient-derived iPSC-derived lines carrying Emery-Dreifuss muscular dystrophy (EDMD) associated mutations. EDMD is a rare muscular dystrophy most commonly caused by pathogenic variants in the LMNA gene. Read more here: linkedin.com/feed/update/ur…

As we count down to Rare Disease Day on February 28, we at @GreenstoneBio will be spotlighting rare diseases represented in our iPSC biobank. This week, we are highlighting neuromuscular rare diseases. Read more here: linkedin.com/posts/greensto…

Earlier this week, our Co-Founder @Joseph_C_Wu, was featured as a guest on the @stemcellpodcast, discussing his work with iPSCs, vaccine-induced myocarditis, and New Approach Methodologies (NAMs). You can listen to the full episode here: stemcellpodcast.com/ep-313-cardiov…

300+ million people worldwide are living with a rare disease. In the US alone, 1 in 10 Americans is affected. At Greenstone Biosciences, supporting research into rare diseases with our iPSC biobank is a core focus of our mission. Learn more here: linkedin.com/posts/greensto…

@GreenstoneBio is offering patient-derived iPSC-derived lines carrying Facioscapulohumeral muscular dystrophy (FSHD). FSHD is one of the most common inherited muscular dystrophies, affecting nearly 1 in 8,000 individuals worldwide Read more Here: linkedin.com/posts/greensto…

Earlier this week @GreenstoneBio Co-Founder @Joseph_C_Wu spoke at the WuXi Global Forum 2026 in San Francisco, joining leaders from @UCSF, @arenabioworks, and the @parkerici to discuss what we should strive toward for patients. Read more here: linkedin.com/posts/greensto…

Earlier this week @GreenstoneBio Co-Founder @Joseph_C_Wu spoke at the WuXi Biologics Global Forum 2026 in San Francisco, joining leaders from @UCSF, @arenabioworks, and the @parkerici to discuss what we should strive toward for patients. Read more: linkedin.com/posts/greensto…

Last Sunday, Greenstone Founder Dr. Joseph C. Wu moderated a debate at the UCSF-CERSI conference on the future of animal testing and the rapid advances with NAMs. These are the discussions the field needs, and we’re proud to see our founder driving them forward!

In case you missed it live, the newest Greenstone Biosciences Webinar featuring Dr. Mark Mercola, Professor of Medicine and Professor in the @StanfordCVI is now available to watch for free online! Watch it here: youtube.com/watch?v=k3yhl2…